Vaccines to curb F&P Healthcare sales

Vaccines to curb F&P Healthcare sales
Dan Brunskill
Shares in Fisher & Paykel Healthcare surged last week as investors were swayed by sustained high sales numbers, but Forsyth Barr is warning demand may begin to fade as covid vaccinations roll out globally.The healthcare manufacturer saw its shares jump more than 5 percent on Friday on the news that revenue was up 73 percent in the nine months ended December, pulling the stock back above $35.Chief executive Lewis Gradon said high rates of covid-19 hospitalisations had driven strong demand for its hospital products, which are used as a front-...

More Markets

NZ sharemarket drops after weak GDP data
Markets Market Close

NZ sharemarket drops after weak GDP data

Stats NZ data showed NZ's gross domestic product fell 0.9% in the June quarter.

Craigs beefs up in Hawkes Bay, eyes further expansion
Finance

Craigs beefs up in Hawkes Bay, eyes further expansion

Craigs looks to further expansion as it confirms the Somerset Smith Partners deal.

NZ dollar on watch ahead of 3Q GDP, Fed signals
Markets

NZ dollar on watch ahead of 3Q GDP, Fed signals

Economists expect NZ GDP to shrink 0.3% in the June quarter after March growth.

Seeking a faster, sharper ComCom
Economy

Seeking a faster, sharper ComCom

A ‘gold standard’ approach and siloed structure slow the ComCom down.